-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's Intraday Session
Share
Listen to the news

Gainers

  • bioAffinity Technologies (NASDAQ:BIAF) stock moved upwards by 54.3% to $10.17 during Wednesday's regular session. The company's market cap stands at $3.9 million.
  • Gelteq (NASDAQ:GELS) shares increased by 41.4% to $0.75. The market value of their outstanding shares is at $5.6 million.
  • Purple Biotech (NASDAQ:PPBT) stock moved upwards by 37.27% to $2.28. The company's market cap stands at $1.5 million.
  • ENDRA Life Sciences (NASDAQ:NDRA) shares rose 21.06% to $6.38. The market value of their outstanding shares is at $7.9 million.
  • OmniAb (NASDAQ:OABI) stock moved upwards by 19.7% to $5.32. The company's market cap stands at $643.6 million.
  • Definitive Healthcare (NASDAQ:DH) shares rose 15.81% to $1.04. The market value of their outstanding shares is at $96.3 million.

Losers

  • TScan Therapeutics (NASDAQ:TCRX) stock declined by 42.7% to $0.38 during Wednesday's regular session. The company's market cap stands at $45.1 million.
  • CDT Equity (NASDAQ:CDT) shares declined by 35.48% to $0.95. The market value of their outstanding shares is at $1.1 million.
  • Can Fite Biopharma (AMEX:CANF) shares fell 23.71% to $2.51. The company's market cap stands at $7.0 million.
  • Apimeds Pharmaceuticals (AMEX:APUS) shares fell 21.76% to $2.77. The market value of their outstanding shares is at $5.3 million.
  • Lakewood-Amedex (NASDAQ:LABT) shares fell 15.95% to $2.32. The market value of their outstanding shares is at $6.5 million.
  • BioXcel Therapeutics (NASDAQ:BTAI) shares declined by 15.48% to $0.12. The company's market cap stands at $4.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending